Proteomic analysis for early detection of ovarian cancer: A realistic approach?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Gynecologic Cancer

• Publication date

  2003-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ijgc-00009577-200311001-00001PMID 14656269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2003

  2003cited by this paper
• Specific keynote: ovarian cancer risk assessment and the potential for early detection.

  2003cited by this paper
• General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

  2003cited by this paper
• The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics.

  2002cited by this paper
• Clinical proteomics: translating benchside promise into bedside reality

  2002cited by this paper
• Screening for ovarian cancer-risk, education, worry: path to appropriate use?

  2002cited by this paper
• The significance of serum CA 125 elevation in malignant and nonmalignant diseases.

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.

  2002cited by this paper
• Screening for ovarian cancer.

  2002cited by this paper
• Serum proteomic patterns for detection of prostate cancer.

  2002cited by this paper
• Elevated CA 125 in Breast Cancer – A Sign of Advanced Disease

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

  2001cited by this paper
• Regulation of growth factor induced gene expression by calcium signalling: Integrated mRNA and protein expression analysis

  2001cited by this paper
• Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction.

  2001cited by this paper
• Clinical proteomics: personalized molecular medicine.

  2001cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• Recent developments in ovarian cancer screening

  2000cited by this paper
• Screening for ovarian cancer: a pilot randomised controlled trial.

  1999cited by this paper
• Role of prophylactic surgery for women with genetic predisposition to cancer.

  1998cited by this paper
• Principles and Practice of Gynecologic Oncology

  1997cited by this paper
• Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.

  1996cited by this paper
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996cited by this paper
• Camptothecin Resistance Related to Drug‐induced Down‐Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein‐linked DNA Breaks a

  1996cited by this paper
• Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers

  1995cited by this paper
• Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.

  1995cited by this paper
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray

  1995cited by this paper
• Principles and Practice of Gynecologic Oncology

  1992cited by this paper
• Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy.

  1990cited by this paper
• Tribute to Patrick Steptoe: beginnings of laparoscopy.

  1989cited by this paper
• The CA 125 tumour-associated antigen: a review of the literature.

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• [What...about tumor markers].

  1988cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper

• Novel 5-(2-phenylbenzo[b]thiophen-3-yl)furan-2-carbaldehyde based ovarian cancer carbohydrate antigen 125 electrochemical sensor

  2022cites this paper
• Metal Assisted Protein quantitation (MAPq): Multiplex analysis of protein expression using lanthanide-modified antibodies with detection by inductively coupled plasma mass spectrometry.

  2020cites this paper
• Comparative Study on Different Classification Techniques for Ovarian Cancer Detection

  2019cites this paper
• Dual Modality Optical Coherence Tomography and Multispectral Fluorescence Imaging for Ovarian Cancer Detection

  2017cites this paper
• Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins.

  2016cites this paper
• Design of luciferase-displaying protein nanoparticles for use as highly sensitive immunoassay detection probes.

  2016cites this paper
• MOLECULAR INVESTIGATION AND DETECTION OF PROTEIN BIOMARKER/S IN POLYCYSTIC OVARY SYNDROME

  2015cites this paper
• Estudio comparativo entre cirugía primaria y cirugía de intervalo en el estadio iiic del cáncer de ovario

  2014cites this paper
• High throughput immunosenor based on multi-label strategy and a novel array electrode

  2014cites this paper
• Detection of Cancer Biomarkers on Biosensor Surfaces

  2014cites this paper
• Elastomeric Capture Microparticles (ECµPs) and Their Use with Acoustophoresis to Perform Affinity Capture Assays

  2013influential citation
• Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.

  2013cites this paper
• GOLD NANOPARTICLES-BASED BIOSENSORS FOR BIOMEDICAL APPLICATION

  2012cites this paper
• Recent trends in antibody based sensors.

  2012cites this paper
• Vorsorge und Nachsorge beim Ovarialkarzinom

  2011cites this paper
• Simultaneous immobilization of glucose oxidase on the surface and cavity of hollow gold nanospheres as labels for highly sensitive electrochemical immunoassay of tumor marker.

  2011cites this paper
• Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particles.

  2011cites this paper
• Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification.

  2010cites this paper
• The Power of the Web in Cancer Drug Discovery and Clinical Trial Design: Research without a Laboratory?

  2010cites this paper
• Electrochemical immunoassay of hepatitis B surface antigen by the amplification of gold nanoparticles based on the nanoporous gold electrode.

  2010cites this paper
• Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.

  2010cites this paper
• Proteomic Profiling in Ovarian Cancer

  2009cites this paper
• Designing nanomaterial-enhanced electrochemical immunosensors for cancer biomarker proteins.

  2009cites this paper
• Ten years of “Optimal Therapy in Advanced Ovarian Cancer. Update” Meeting

  2008cites this paper
• Ovarian cancer diagnosis with complementary learning fuzzy neural network

  2008cites this paper
• Ovarian cancer diagnosis with complementary learning fuzzy neural network

  2008cites this paper
• Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers

  2008cites this paper
• Präventionsstrategien beim Ovarialkarzinom

  2008cites this paper
• Chapter 10 – The Adnexal Mass and Early Ovarian Cancer

  2007cites this paper
• Carbon Nanotubes for Electronic and Electrochemical Detection of Biomolecules

  2007cites this paper
• Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.

  2007cites this paper
• Multiple biomarker panels for early detection of ovarian cancer.

  2006cites this paper
• A review and an update on the screening of epithelial ovarian cancer.

  2006cites this paper
• Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers.

  2006cites this paper
• Proteomics in Gynecologic Malignancies

  2006cites this paper
• Single-walled carbon-nanotube forest immunosensor for amplified detection of cancer biomarkers

  2006cites this paper
• Proteomics profile changes in cisplatin-treated human ovarian cancer cell strain

  2005cites this paper
• Synergistic approaches to clinical oncology biomarker discovery.

  2005cites this paper
• Effects of progesterone on ovarian tumorigenesis in xenografted mice.

  2005cites this paper
• Proteomic Cancer Classification with Mass Spectrometry Data

  2005cites this paper
• Ovarian cancer: is the news good enough?

  2005cites this paper
• Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification.

  2005cites this paper
• Current and Future Therapeutic Targets of the Tumour-Host Microenvironment

  2005cites this paper
• The molecular make-up of a tumour: proteomics in cancer research.

  2005cites this paper
• Ovarian cancer diagnosis using complementary learning fuzzy neural network

  2005cites this paper
• Proteomic Strategies and their Application in Cancer Research

  2005cites this paper
• Ultrafiltration for proteomic sample preparation

  2004cites this paper
• Proteomics in cancer.

  2004cites this paper
• Ovarian cancer treatment: what is new

  2003cites this paper
• Cancer in women

  2003cites this paper